Utilizing Remote Patient Monitoring Tools to Evaluate Novel Implanted Cardiac Devices for Heart Failure Patients - A Case Series
Main Article Content
Abstract
Heart failure (HF) remains a leading cause of morbidity, mortality, and healthcare expenditures. A surge in novel technologies targeting different components of chronic HF pathophysiology has emerged, including the CardioMEMS pulmonary artery pressure monitor, the carotid barostimulator (Barostim Neo™) and the Bodyport cardiac scale. Despite the growing availability of remote solutions, the limited availability of robust studies has led to lower-level recommendations by national cardiology societies which may limit their adoption. One way to generate practical application data is by integrating established real-time hemodynamic monitoring devices with novel innovations, providing real-world evidence to support emerging solutions. In this case series, we review remote patient monitoring tools and their ability to evaluate novel implanted cardiovascular devices. This study aims to illustrate the benefit of clinical integration of these technologies and advocate for further use of this approach to enhance their real-world applicability in patient care.
Keywords:
Heart failure, Remote patient monitoring, Implanted cardiac devices, CardioMEMS, Barostim Neo, Bodyport scale, Hemodynamic monitoring
Article Details
How to Cite
DOSHI, Pratik et al.
Utilizing Remote Patient Monitoring Tools to Evaluate Novel Implanted Cardiac Devices for Heart Failure Patients - A Case Series.
Medical Research Archives, [S.l.], v. 13, n. 4, apr. 2025.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/6414>. Date accessed: 05 dec. 2025.
doi: https://doi.org/10.18103/mra.v13i4.6414.
Section
Case Reports
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG; American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013 May;6(3):606-19. doi: 10.1161/HHF.0b013e318291 329a. Epub 2013 Apr 24. PMID: 23616602; PMCID: PMC3908895.
2. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007 Sep 25;116 (13):1482-7. doi: 10.1161/CIRCULATIONAHA.107.6969 06. Epub 2007 Aug 27. PMID: 17724259.
3. Creaser JW, DePasquale EC, Vandenbogaart E, et al. Team-based care for outpatients with heart failure. Heart Fail Clin. 2015;11:379–405.
4. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, La Gerche A, Ligibel JA, Lopez G, Madan K, Oeffinger KC, Salamone J, Scott JM, Squires RW, Thomas RJ, Treat-Jacobson DJ, Wright JS; American Heart Association Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Peripheral Vascular Disease. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association. Circulation. 2019 May 21;139(21):e9 97-e1012. doi: 10.1161/CIR.0000000000000679. PMID: 30955352
5. Fudim M, Yazdi D, Egolum U, Haghighat A, Kottam A, Sauer AJ, Shah H, Kumar P, Rakita V, Centen C, Ozonat K, Smith S, DeVore AD. (2023). Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1. Circulation: Heart Failure, 16(5), e010012. doi:10. 1161/CIRCHEARTFAILURE.122.010012.
6. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–666.
7. Ciotola F, Pyxaras S, Rittger H, Buia V. (2024). MEMS Technology in Cardiology: Advancements and Applications in Heart Failure Management Focusing on the CardioMEMS Device. Sensors (Basel, Switzerland), 24(9), 2922. doi:10.3390/s24092922.
8. Manavi T, Zafar H, Sharif F. (2024). An Era of Digital Healthcare—a Comprehensive Review of Sensor Technologies and Telehealth Advancements in Chronic Heart Failure Management. Sensors (Basel, Switzerland), 24(8), 2546. doi:10.3390/s24082546.
9. Heart Failure Society of America (HFSA). (2024). HFSA Scientific Statement: Update on Device-Based Therapies in Heart Failure. Available at: https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics (Accessed: 27 February 2025).
10. Reed GW, Harmon EK, Harb S, et al. Design and Rationale of the v-Wave Shunt MitraClip Study. Am J Cardiol. 2024;227:29-36. doi:10.1016/j.amjcard.2024.06.023.
11. Fudim M, Centen C, Mahoney D, et al. Surveillance and alert-based multiparameter monitoring to reduce worsening heart failure events: results from SCALE-HF 1. J Card Fail. 2024;30(2):145-153. doi:10.1016/j.cardfail. 2023.11.005.
12. Zile MR, Abraham WT, Weaver FA, et al. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: long-term outcomes. Eur J Heart Fail. 2024;26(4):1051-1061. doi:10.1002/ejhf.3232.
13. Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomized trial. Lancet. 2016;387(10017):453-461. doi:10.1016/S01 40-6736(15)00723-0.
14. Zile, M, Lindenfeld, J, Weaver, F. et al. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2020 Jul, 76 (1) 1–13. https://doi.org/10.1016/j.jacc.2020.05.015
15. Radhoe, S. P., Clephas, P. R. D., Mokri, H., & Brugts, J. J. (2023). The CardioMEMS Heart Failure System for chronic heart failure – a European perspective. Expert Review of Medical Devices, 20(5), 349–356. https://doi.org/10.1080/17434440.2023.2196400
16. Doshi, P, Valdivia, D, Pham, V. et al. ASSESSING THE EFFICACY OF BARORECEPTOR ACTIVATION THERAPY USING REMOTE PATIENT MONITORING: A CASE STUDY. J Am Coll Cardiol. 2024 Apr, 83 (13_Supplement) 3962. https://doi.org/10.1016/S0735-1097(24)05952-7
17. Goodman, R, Aldea, D, Huang, C. et al. CASE OF CARDIAC SCALE AUGMENTING CARDIOMEMS TO ASSESS VOLUME STATUS IN OUTPATIENT HEART FAILURE MANAGEMENT. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 3467. https://doi.org/10.1016/S0735-1097(23)03911-6
18. Stone GW, Lindenfeld J, Rodés-Cabau J, Anker SD, Zile MR, Kar S, Holcomb R, Pfeiffer MP, Bayes-Genis A, Bax JJ, Bank AJ, Costanzo MR, Verheye S, Roguin A, Filippatos G, Núñez J, Lee EC, Laufer-Perl M, Moravsky G, Litwin SE, Prihadi E, Gada H, Chung ES, Price MJ, Thohan V, Schewel D, Kumar S, Kische S, Shah KS, Donovan DJ, Zhang Y, Eigler NL, Abraham WT; RELIEVE-HF Investigators. Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial. Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23. PMID: 39308371; PMCID: PMC11627316.
2. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007 Sep 25;116 (13):1482-7. doi: 10.1161/CIRCULATIONAHA.107.6969 06. Epub 2007 Aug 27. PMID: 17724259.
3. Creaser JW, DePasquale EC, Vandenbogaart E, et al. Team-based care for outpatients with heart failure. Heart Fail Clin. 2015;11:379–405.
4. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, La Gerche A, Ligibel JA, Lopez G, Madan K, Oeffinger KC, Salamone J, Scott JM, Squires RW, Thomas RJ, Treat-Jacobson DJ, Wright JS; American Heart Association Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Peripheral Vascular Disease. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association. Circulation. 2019 May 21;139(21):e9 97-e1012. doi: 10.1161/CIR.0000000000000679. PMID: 30955352
5. Fudim M, Yazdi D, Egolum U, Haghighat A, Kottam A, Sauer AJ, Shah H, Kumar P, Rakita V, Centen C, Ozonat K, Smith S, DeVore AD. (2023). Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1. Circulation: Heart Failure, 16(5), e010012. doi:10. 1161/CIRCHEARTFAILURE.122.010012.
6. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–666.
7. Ciotola F, Pyxaras S, Rittger H, Buia V. (2024). MEMS Technology in Cardiology: Advancements and Applications in Heart Failure Management Focusing on the CardioMEMS Device. Sensors (Basel, Switzerland), 24(9), 2922. doi:10.3390/s24092922.
8. Manavi T, Zafar H, Sharif F. (2024). An Era of Digital Healthcare—a Comprehensive Review of Sensor Technologies and Telehealth Advancements in Chronic Heart Failure Management. Sensors (Basel, Switzerland), 24(8), 2546. doi:10.3390/s24082546.
9. Heart Failure Society of America (HFSA). (2024). HFSA Scientific Statement: Update on Device-Based Therapies in Heart Failure. Available at: https://hfsa.org/hf-stats-2024-heart-failure-epidemiology-and-outcomes-statistics (Accessed: 27 February 2025).
10. Reed GW, Harmon EK, Harb S, et al. Design and Rationale of the v-Wave Shunt MitraClip Study. Am J Cardiol. 2024;227:29-36. doi:10.1016/j.amjcard.2024.06.023.
11. Fudim M, Centen C, Mahoney D, et al. Surveillance and alert-based multiparameter monitoring to reduce worsening heart failure events: results from SCALE-HF 1. J Card Fail. 2024;30(2):145-153. doi:10.1016/j.cardfail. 2023.11.005.
12. Zile MR, Abraham WT, Weaver FA, et al. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: long-term outcomes. Eur J Heart Fail. 2024;26(4):1051-1061. doi:10.1002/ejhf.3232.
13. Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomized trial. Lancet. 2016;387(10017):453-461. doi:10.1016/S01 40-6736(15)00723-0.
14. Zile, M, Lindenfeld, J, Weaver, F. et al. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2020 Jul, 76 (1) 1–13. https://doi.org/10.1016/j.jacc.2020.05.015
15. Radhoe, S. P., Clephas, P. R. D., Mokri, H., & Brugts, J. J. (2023). The CardioMEMS Heart Failure System for chronic heart failure – a European perspective. Expert Review of Medical Devices, 20(5), 349–356. https://doi.org/10.1080/17434440.2023.2196400
16. Doshi, P, Valdivia, D, Pham, V. et al. ASSESSING THE EFFICACY OF BARORECEPTOR ACTIVATION THERAPY USING REMOTE PATIENT MONITORING: A CASE STUDY. J Am Coll Cardiol. 2024 Apr, 83 (13_Supplement) 3962. https://doi.org/10.1016/S0735-1097(24)05952-7
17. Goodman, R, Aldea, D, Huang, C. et al. CASE OF CARDIAC SCALE AUGMENTING CARDIOMEMS TO ASSESS VOLUME STATUS IN OUTPATIENT HEART FAILURE MANAGEMENT. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 3467. https://doi.org/10.1016/S0735-1097(23)03911-6
18. Stone GW, Lindenfeld J, Rodés-Cabau J, Anker SD, Zile MR, Kar S, Holcomb R, Pfeiffer MP, Bayes-Genis A, Bax JJ, Bank AJ, Costanzo MR, Verheye S, Roguin A, Filippatos G, Núñez J, Lee EC, Laufer-Perl M, Moravsky G, Litwin SE, Prihadi E, Gada H, Chung ES, Price MJ, Thohan V, Schewel D, Kumar S, Kische S, Shah KS, Donovan DJ, Zhang Y, Eigler NL, Abraham WT; RELIEVE-HF Investigators. Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial. Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23. PMID: 39308371; PMCID: PMC11627316.